Metavex Tablet
NDC Package 85477-503-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Metavex tablets is metavex™ is indicated as a prescription dietary supplement for the dietary management of individuals with metabolic health needs where folic acid supplementation is appropriate.Administration: Take two (2) tablets daily with a 12-ounce glass of water, or as directed by a licensed healthcare practitioner. This formulation utilizes a tablet delivery system. Marketed by Oncora Pharma, Llc, this product is identified by NDC 85477-503.

Identification & Billing

NDC Package Code
85477-503-30
Package Description
1 TABLET in 1 BOTTLE
Product Code
85477-503
11-Digit Billing Format
85477050330

Clinical Specifications

Proprietary Name
Metavex
Non-Proprietary Name
Metavex
Substance Name
Aloe Ferox Leaf; Blue Agave Inulin (agave Tequilana); Cholecalciferol; Elm; Folic Acid; Rhamnus Cathartica Bark
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Metavex™ is indicated as a prescription dietary supplement for the dietary management of individuals with metabolic health needs where folic acid supplementation is appropriate.Administration: Take two (2) tablets daily with a 12-ounce glass of water, or as directed by a licensed healthcare practitioner.

Regulatory & Marketing

Labeler Name
Oncora Pharma, Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-01-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85477-503-30 identifies a specific commercial package of 1 tablet in 1 bottle of Metavex, a human prescription drug labeled by Oncora Pharma, Llc. This tablet is formulated for oral use and contains aloe ferox leaf; blue agave inulin (agave tequilana); cholecalciferol; elm; folic acid; rhamnus cathartica bark as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Oncora Pharma, Llc on January 01, 2026. The current certification is valid through December 31, 2027.

How is this Oncora Pharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85477050330. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85477-503-30
11-Digit CMS (5-4-2)
85477-0503-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.